Novel gemcitabine-containing triplets in the management of urothelial cancer

被引：10

作者：

Hussain, M

Vaishampayan, U

Smith, DC

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[2] Barbara Ann Karmanos Canc Inst, Detroit, MI USA

[3] Wayne State Univ, Div Hematol Oncol, Detroit, MI 48202 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期

关键词：

D O I：

10.1053/sonc.2002.30753

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：20 / 24

页数：5

共 15 条

[1] Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium [J].

Bellmunt, J ;

Guillem, V ;

Paz-Ares, L ;

González-Larriba, JL ;

Carles, J ;

Batiste-Alentorn, E ;

Sáenz, A ;

López-Brea, M ;

Font, A ;

Nogué, M ;

Bastús, R ;

Climent, MA ;

de la Cruz, JJ ;

Albanell, J ;

Banús, JM ;

Gallardo, E ;

Diaz-Rubio, E ;

Cortés-Funes, H ;

Baselga, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3247-3255

[2] Phase I evaluation of sequential doxorubicin plus gemcitabine then ifosfamide plus paclitaxel plus cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract [J].

Dodd, PM ;

McCaffrey, JA ;

Hilton, S ;

Mazumdar, M ;

Herr, H ;

Kelly, WK ;

Icasiano, E ;

Boyle, MG ;

Bajorin, DF .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :840-846

[3] Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: An Eastern Cooperative Oncology Group study [J].

Dreicer, R ;

Manola, J ;

Roth, BJ ;

Cohen, MB ;

Hatfield, AK ;

Wilding, G .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) :1058-1061

[4]

HOVEY EJ, 2000, P AN M AM SOC CLIN, V19, pA350

[5] Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer [J].

Hussain, M ;

Vaishampayan, U ;

Du, W ;

Redman, B ;

Smith, DC .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2527-2533

[6] Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer [J].

Kaufman, D ;

Raghavan, D ;

Carducci, M ;

Levine, EG ;

Murphy, B ;

Aisner, J ;

Kuzel, T ;

Nicol, S ;

Oh, W ;

Stadler, W .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) :1921-1927

[7]

LINDNER H, 2000, P AN M AM SOC CLIN, V19, pA353

[8] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial [J].

Lorusso, V ;

Manzione, L ;

De Vita, F ;

Antimi, M ;

Selvaggi, FP ;

De Lena, M .

JOURNAL OF UROLOGY, 2000, 164 (01) :53-56

[9] Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada clinical trials group [J].

Moore, MJ ;

Winquist, EW ;

Murray, N ;

Tannock, IF ;

Huan, S ;

Bennett, K ;

Walsh, W ;

Seymour, L .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2876-2881

[10]

Raghavan D, 2000, Eur J Cancer, V36 Suppl 2, P1, DOI 10.1016/S0959-8049(00)00075-7

← 1 2 →